Fundz

Actinium Appoints Lynn Bodarky as Chief Business Officer

PUBLIC · ATNMNov 03, 2023

Position

Chief Business Officer

Company

Actinium Pharmaceuticals

Lynn Bodarky
lbodarky@actiniumpharma.com
New YorkBiotechnologyHealth CareTherapeutics

Description

Actinium Pharmaceuticals, Inc. , a leader in the development of targeted radiotherapies, today announced that Lynn Bodarky has been named Chief Business Officer to lead the Company's business development, licensing, and collaboration activities

Quick answer

Actinium Appoints Lynn Bodarky as Chief Business Officer (November 3, 2023). Actinium Pharmaceuticals is based in New York, New York, United States.

Who is the new Chief Business Officer at Actinium Pharmaceuticals?
Actinium Pharmaceuticals named Lynn Bodarky Chief Business Officer, announced November 3, 2023.
What did Actinium Pharmaceuticals announce on November 3, 2023?
Actinium Pharmaceuticals, Inc. , a leader in the development of targeted radiotherapies, today announced that Lynn Bodarky has been named Chief Business Officer to lead the Company's business development, licensing, and collaboration activities
What does Actinium Pharmaceuticals do?
Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers.
Where is Actinium Pharmaceuticals based?
Actinium Pharmaceuticals is based in New York, New York, United States.
Which similar companies made leadership changes around the same time?
vTv Therapeutics Inc. (November 2, 2023), BioMarin Pharmaceutical (November 1, 2023), Corcept (November 1, 2023) and Faeth Therapeutics (November 1, 2023) also announced leadership changes within 45 days of Actinium Pharmaceuticals.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Actinium Pharmaceuticals, and when

A new leader at Actinium Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Actinium Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Actinium Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Actinium Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Actinium Pharmaceuticals

Location

New York, New York, United States

About

Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently Investigating therapies in #AML and #BMT

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Actinium Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Sandesh
Senior decision-maker at this company
••••••••@••••••••

See Sandesh's verified email →

Matt
Likely contact at this company
••••••••@••••••••

See Matt's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Actinium Pharmaceuticals's next move

Learn about Strategic plan

Actinium Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.